Legal & General Group Plc - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 189 filers reported holding IMMUNOGEN INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$3,405,305
-15.1%
214,575
+1.0%
0.00%0.0%
Q2 2023$4,010,798
+1029.4%
212,549
+129.8%
0.00%
Q1 2023$355,142
-16.9%
92,485
+7.3%
0.00%
Q4 2022$427,508
+5.3%
86,191
+1.5%
0.00%
Q3 2022$406,000
+15.0%
84,955
+8.2%
0.00%
Q2 2022$353,000
-7.1%
78,492
-1.7%
0.00%
Q1 2022$380,000
-34.4%
79,880
+2.4%
0.00%
Q4 2021$579,000
+35.3%
78,043
+3.2%
0.00%
Q3 2021$428,000
+74.7%
75,610
+103.6%
0.00%
Q2 2021$245,000
-18.3%
37,129
+0.1%
0.00%
Q1 2021$300,000
+40.2%
37,077
+11.7%
0.00%
Q4 2020$214,000
+60.9%
33,193
-9.9%
0.00%
Q3 2020$133,000
-35.1%
36,831
-17.3%
0.00%
Q2 2020$205,000
+36.7%
44,519
+1.1%
0.00%
Q1 2020$150,000
-25.4%
44,016
+11.7%
0.00%
Q4 2019$201,000
+120.9%
39,420
+4.8%
0.00%
Q3 2019$91,000
+56.9%
37,617
+41.6%
0.00%
Q2 2019$58,000
-19.4%
26,5720.0%0.00%
Q1 2019$72,000
-43.8%
26,5720.0%0.00%
Q4 2018$128,000
-41.3%
26,572
+15.8%
0.00%
Q3 2018$218,000
+9.0%
22,951
+11.6%
0.00%
Q2 2018$200,000
-1.0%
20,559
+7.2%
0.00%
Q1 2018$202,000
+27.0%
19,184
-21.6%
0.00%
Q4 2017$159,000
-2.5%
24,459
+13.6%
0.00%
Q3 2017$163,000
-11.4%
21,526
-16.2%
0.00%
Q2 2017$184,000
+85.9%
25,6850.0%0.00%
Q1 2017$99,000
+94.1%
25,685
-8.5%
0.00%
Q4 2016$51,000
+27.5%
28,065
+88.9%
0.00%
Q3 2016$40,000
-40.3%
14,858
-31.6%
0.00%
Q2 2016$67,000
-64.4%
21,7240.0%0.00%
Q1 2016$188,000
-27.1%
21,724
+13.2%
0.00%
Q4 2015$258,000
+38.0%
19,1860.0%0.00%
Q3 2015$187,000
+8.1%
19,186
+55.7%
0.00%
Q2 2015$173,000
+53.1%
12,3200.0%0.00%
Q1 2015$113,000
+46.8%
12,3200.0%0.00%
Q4 2014$77,000
-43.0%
12,3200.0%0.00%
Q3 2014$135,00012,3200.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2019
NameSharesValueWeighting ↓
Redmile Group, LLC 3,984,734$15,421,0001.00%
Moloney Securities Asset Management, LLC 274,450$1,062,0000.55%
Schonfeld Strategic Advisors LLC 1,025,176$3,968,0000.40%
Orbimed Advisors 6,095,647$23,590,0000.27%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$438,0000.26%
PINNACLE ASSOCIATES LTD 1,589,959$6,153,0000.12%
Baker Brothers Advisors 3,015,353$11,669,0000.10%
BAXTER BROS INC 58,000$224,0000.07%
SIMON QUICK ADVISORS, LLC 25,000$97,0000.06%
Northeast Financial Consultants Inc 34,315$133,0000.06%
View complete list of IMMUNOGEN INC shareholders